Ongoing Disclosure Notice – S Botherway

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer: Serko Limited
Date this disclosure made:
Date of last disclosure: 5-Nov-20
Director or senior manager giving disclosure
Full name(s):Simon Botherway
Name of listed issuer:Serko Limited
Name of related body corporate (if applicable):Not applicable
Position held in listed issuer:Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Ordinary shares
Nature of the affected relev ant interest(s):1. Registered holder and beneficial owner
2. Registered holder and beneficial owner by
virtue of being a trustee of the Arrow Trust
For that relevant interest-
Number held in class before acquisition or disposal:1. 284,909 ordinary shares
2. 884,091 ordinary shares
Number held in class after acquisition or disposal:1. 234,909 ordinary shares
2. 0 ordinary shares
Current registered holder(s):1. Simon Botherway
2. Simon John Botherway and MSH Trustee
(Arrow) Limited acting jointly in their
capacities as trustees of The Arrow Trust
Reg istered holder(s) once transfers are reg istered:Unk nown
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2
Details of transactions requiring disclosure-
Date of transaction:20-Nov-20
Nature of transaction: 1. On market sale of ordinary shares.
2. On market sale of ordinary shares.
Name of any other party or parties to the transaction (if k nown):Unk nown
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If
the consideration was not in cash and cannot be readily by conv erted into a cash v alue, describe the
consideration:
1. $264,000.00 ($5.28/share)
2. $4,644,660.48 ($5.28/share)
Number of financial products to which the transaction related: 1. Sale of 50,000 shares
2. Sale of 884,091 shares
If the issuer has a financial products trading policy that prohibits directors or senior managers from
trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the
closed period:
Not applicable
Date of the prior written clearance (if any):Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Ordinary shares
Nature of relev ant interest:Beneficial owner
For that relevant interest,-
Number held in class:42,070.10 ordinary shares held under the
Serko NED Fixed Trading Plan
Current registered holder(s):Custodian S erv ices Limited as custodian for
Simon Botherway
For a derivative relevant interest,-
23-Nov-20

Type of derivative:Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if
any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:Not applicable
Maturity date of the derivative (if any):Not applicable
Expiry date of the derivative (if any):Not applicable
The price's specified terms (if any):Not applicable
Any other details needed to understand how the amount of the consideration payable under the
deriv ativ e or the v alue of the deriv ativ e is affected by the v alue of the underly ing financial products:
Not applicable
For that derivative relevant interest,-
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the
deriv ativ e:
Not applicable
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is
correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
23-Nov-20